Pulmicort Aerosol, Powder
Product Images NDC 61269-518

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Pulmicort (NDC 61269-518). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H2-pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pulmicort Flexhaler 180mcg Carton Label 120 Metered Doses (Carton 180 mg)

Box packaging label for Pulmicort Flexhaler 180 mcg, an inhalation powder containing budesonide. The label indicates 120 metered doses for oral inhalation, with usage and storage instructions. It includes the NDC 61269-518-12 and distributor H2-Pharma LLC, licensed by CHEPLAPHARM Arzneimittel GmbH.*

FDA Label Image

Pulmicort Flexhaler 90 Mcg Carton Label 60 Metered Doses (Carton 90 mg)

Packaging label for Pulmicort Flexhaler 90 mcg aerosol powder for inhalation. The label is primarily teal, white, and purple, showing the product name and strength prominently. It states 60 metered doses for oral inhalation and is labeled for prescription use only. The labeler is Cheplapharm, distributed by H2-Pharma LLC.*

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram showing the molecular structure of budesonide, the active ingredient in PULMICORT FLEXHALER. The image displays the detailed arrangement of atoms and bonds characteristic of budesonide.*

FDA Label Image

Figure 1 (Image 02)

A line graph showing changes in FEV1 (L) over a 12-week period for three groups: PULMICORT FLEXHALER 180 mcg, PULMICORT TURBUHALER 200 mcg, and placebo. The x-axis represents weeks, while the y-axis shows change in FEV1 in liters. Both PULMICORT groups show greater improvement compared to placebo over time.*

FDA Label Image

Figure 2 (Image 03)

A line graph comparing the percentage change in predicted FEV1 over a 12-week period among three groups: PULMICORT FLEXHALER 90 mcg, PULMICORT TURBUHALER 200 mcg, and placebo. The graph shows increasing FEV1 changes for both active treatments, with PULMICORT FLEXHALER demonstrating a slightly higher improvement than PULMICORT TURBUHALER, while the placebo group remains near baseline.*

FDA Label Image

Figure 1 (Image 04)

An instructional diagram showing components of the PULMICORT FLEXHALER inhaler device, including the mouthpiece, dose indicator, brown grip, and removable cover. The image outlines parts relevant for inhalation use and dose tracking.*

FDA Label Image

Figure 2 (Image 05)

An instructional illustration showing a person holding and preparing the PULMICORT FLEXHALER inhalation device by using both hands, likely demonstrating how to load or activate the device before inhalation. The drawing focuses on hand placement around the inhaler.*

FDA Label Image

Figure 3 (Image 06)

An instructional illustration showing a hand holding a Pulmicort Flexhaler inhaler, demonstrating the twisting motion needed to prepare the device for use. The image is labeled "Twist" with an arrow indicating the direction of rotation at the base of the inhaler.*

FDA Label Image

Figure 4 (Image 07)

An instructional illustration showing a hand holding a Pulmicort Flexhaler inhaler device. The hand is gripping the device with the thumb and forefinger, demonstrating preparation or activation of the inhaler. The word "Click" is shown below, indicating an action step in using the inhaler.*

FDA Label Image

Figure 5 (Image 08)

An instructional illustration demonstrating the use of an inhaler device. The image shows a person holding the inhaler close to their mouth, preparing to inhale the medication.*

FDA Label Image

Figure 6 (Image 09)

An instructional diagram showing a close-up view of the dosage counter on a PULMICORT FLEXHALER inhaler device. The counter displays the numbers 100 and 120, indicating dose levels remaining in the device.*

FDA Label Image

Figure 7 (Image 10)

An illustration showing the dose counter window of a PULMICORT FLEXHALER inhaler, indicating the number 20, representing doses remaining.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.